Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity

被引:51
|
作者
Medana, I
Li, ZX
Flügel, A
Tschopp, J
Wekerle, H
Neumann, H
机构
[1] Max Planck Inst Neurobiol, Dept Neuroimmunol, D-82152 Martinsried, Germany
[2] Univ Lausanne, Inst Biochim, CH-1066 Epalinges, Switzerland
来源
JOURNAL OF IMMUNOLOGY | 2001年 / 167卷 / 02期
关键词
D O I
10.4049/jimmunol.167.2.674
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Previous work showed that neurons of the CNS are protected against perforin-mediated T cell cytotoxicity, but are susceptible to Fas-mediated apoptosis. In this study, we report that Fas ligand (FasL) expression by neurons is involved in protection against perforin-mediated T cell cytotoxicity. Gene transcripts for FasL were identified in single murine hippocampal neurons by RT-PCR combined with patch clamp electrophysiology, and constitutive expression of FasL protein was confirmed in neurons by immunohistochemistry. Neurons derived from wild-type C57BL/6 (BL6) mice and mutant BL6.gld mice lacking functional FaSL were confronted with allogeneic, CTLs and continuously monitored in real time for changes in levels of intracellular calcium ([Ca2+](i)), an indicator of cytotoxic damage. Perforin-mediated plasma membrane lysis, characterized by rapid, massive [Ca2+](i) influx into the target cells within 0.5 h, was not detected in wild-type neurons. In striking contrast, FasL-deficient neurons showed rapid increase in [Ca2+](i) within 0.5 h, reflecting perforin-dependent cell lysis. FasL seems to protect neurons by blocking degranulation of CTLs, since CD3-induced release of cytotoxic granules was reduced by coapplication of Fas-specific Abs or rFasL.
引用
收藏
页码:674 / 681
页数:8
相关论文
共 50 条
  • [21] IFN-γ promotes Fas ligand- and perforin-mediated liver cell destruction by cytotoxic CD8 T cells
    Roth, E
    Pircher, H
    JOURNAL OF IMMUNOLOGY, 2004, 172 (03): : 1588 - 1594
  • [22] Fas (CD95), Fas ligand (CD95L), and Bcl-2 expression in human placenta and umbilical cord.
    Uckan, D
    Steele, A
    Wang, B
    Chamizo, W
    Koutsonikolis, A
    Good, RA
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 114 - 114
  • [23] Influence of levothyroxine treatment on serum levels of soluble Fas (CD95) and Fas Ligand (CD95L) in chronic autoimmune hypothyroidism
    Iraj Nabipour
    Mohammadreza Kalantarhormozi
    Majid Assadi
    Seyed Mojtaba Jafari
    Mohammad Gharibi
    Esmaeil Ahmadi
    Zahra Sanjdideh
    Endocrine, 2010, 38 : 406 - 411
  • [24] BCL-2 PROTECTS AGAINST FAS-BASED BUT NOT PERFORIN BASED T-CELL MEDIATED CYTOTOXICITY
    LEE, RK
    SPIELMAN, J
    KAGI, D
    HENGARTNER, H
    PODACK, ER
    FASEB JOURNAL, 1995, 9 (03): : A523 - A523
  • [25] Modification of tumor cells with Fas (CD95) antigen gene and Fas ligand (CD95L) gene transfection by electroporation for immunotherapy of cancer
    Shimizu, M
    Yoshimoto, T
    Matsuzawa, A
    Takeda, Y
    MOLECULAR BIOTECHNOLOGY, 2003, 25 (01) : 79 - 87
  • [26] Modification of tumor cells with fas (CD95) antigen gene and fas ligand (CD95L) gene transfection by electroporation for immunotherapy of cancer
    Motomu Shimizu
    Takayuki Yoshimoto
    Akio Matsuzawa
    Yasutaka Takeda
    Molecular Biotechnology, 2003, 25 : 79 - 87
  • [27] Heightened CD95 (Fas)-CD95L (Fas ligand) interactions and T cell apoptosis in stable cardiac transplant recipients: A potential mechanism for tolerance induction.
    Ankersmit, J
    Moser, B
    Hofmann, M
    Schuster, MD
    Karimova, A
    Wolf, I
    Hericis, R
    Grimm, M
    Kocher, AA
    Edwards, NM
    Wolner, E
    Itescu, S
    TRANSPLANTATION, 2000, 69 (08) : S250 - S250
  • [28] Involvement of CD27/CD70 interactions in antigen-specific cytotoxic T-lymphocyte (CTL) activity by perforin-mediated cytotoxicity
    Yamada, S
    Shinozaki, K
    Agematsu, K
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 130 (03): : 424 - 430
  • [29] Fas ligand (FasL, CD95L, APO-1L) expression in murine mast cells
    Wagelie-Steffen, AL
    Hartmann, K
    Vliagoftis, H
    Metcalfe, DD
    IMMUNOLOGY, 1998, 94 (04) : 569 - 574
  • [30] CD95 (Fas) ligand - A mediator of cytotoxic T lymphocyte-mediated apoptosis and immune privilege
    Duke, RC
    Nash, PB
    Schleicher, MS
    Richards, C
    Moore, J
    Newell, E
    Franzusoff, A
    Bellgrau, D
    PROGRAMMED CELL DEATH, 1997, : 159 - 167